Doximity Inc has a consensus price target of $32.42, established from looking at the 80 latest analyst ratings. The last 3 analyst ratings were released from Needham, Evercore ISI Group, and JP Morgan on May 17, 2024, May 17, 2024, and April 25, 2024. With an average price target of $18 between Needham, Evercore ISI Group, and JP Morgan, there's an implied -35.04% downside for Doximity Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/17/2024 | Buy Now | — | Needham | Scott Berg | — | Reiterates | → Hold | Get Alert |
05/17/2024 | Buy Now | 4.66% | Evercore ISI Group | Elizabeth Anderson | $28 → $29 | Maintains | In-Line | Get Alert |
04/25/2024 | Buy Now | -9.78% | JP Morgan | Anne Samuel | → $25 | Upgrade | Underweight → Neutral | Get Alert |
04/23/2024 | Buy Now | -9.78% | Morgan Stanley | Ricky Goldwasser | $25 → $25 | Maintains | Underweight | Get Alert |
04/02/2024 | Buy Now | 8.26% | Evercore ISI Group | Elizabeth Anderson | → $30 | Maintains | In-Line | Get Alert |
03/15/2024 | Buy Now | -9.78% | JP Morgan | Anne Samuel | $22 → $25 | Maintains | Underweight | Get Alert |
02/26/2024 | Buy Now | 15.48% | Leerink Partners | Michael Cherny | → $32 | Initiates | → Market Perform | Get Alert |
02/09/2024 | Buy Now | 4.66% | Truist Securities | Jailendra Singh | $28 → $29 | Maintains | Hold | Get Alert |
02/09/2024 | Buy Now | -2.56% | Wells Fargo | Stan Berenshteyn | $25 → $27 | Maintains | Equal-Weight | Get Alert |
01/23/2024 | Buy Now | 15.48% | B of A Securities | Allen Lutz | $29 → $32 | Maintains | Neutral | Get Alert |
01/02/2024 | Buy Now | 4.66% | B of A Securities | Allen Lutz | $21 → $29 | Upgrade | Underperform → Neutral | Get Alert |
11/10/2023 | Buy Now | -17% | Piper Sandler | Jessica Tassan | $21 → $23 | Maintains | Neutral | Get Alert |
11/10/2023 | Buy Now | -9.78% | Morgan Stanley | Ricky Goldwasser | $21 → $25 | Maintains | Underweight | Get Alert |
09/05/2023 | Buy Now | 19.09% | Canaccord Genuity | Richard Close | $40 → $33 | Maintains | Buy | Get Alert |
08/11/2023 | Buy Now | -9.78% | Wells Fargo | Stan Berenshteyn | $37 → $25 | Maintains | Equal-Weight | Get Alert |
08/09/2023 | Buy Now | 1.05% | Truist Securities | Jailendra Singh | $33 → $28 | Maintains | Hold | Get Alert |
08/09/2023 | Buy Now | -24.22% | Morgan Stanley | Ricky Goldwasser | $28 → $21 | Maintains | Underweight | Get Alert |
08/09/2023 | Buy Now | — | Guggenheim | Sandy Draper | — | Downgrade | Buy → Neutral | Get Alert |
08/09/2023 | Buy Now | 8.26% | Raymond James | Brian Peterson | $40 → $30 | Maintains | Outperform | Get Alert |
08/09/2023 | Buy Now | — | Needham | Scott Berg | — | Downgrade | Buy → Hold | Get Alert |
08/03/2023 | Buy Now | 29.92% | Piper Sandler | Jessica Tassan | $38 → $36 | Downgrade | Overweight → Neutral | Get Alert |
06/07/2023 | Buy Now | 44.35% | Canaccord Genuity | Richard Close | → $40 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 62.4% | Needham | Scott Berg | → $45 | Reiterates | Buy → Buy | Get Alert |
06/05/2023 | Buy Now | 19.09% | Truist Securities | Jailendra Singh | $36 → $33 | Maintains | Hold | Get Alert |
05/17/2023 | Buy Now | 44.35% | Canaccord Genuity | Richard Close | $41 → $40 | Maintains | Buy | Get Alert |
05/17/2023 | Buy Now | 15.48% | Evercore ISI Group | Elizabeth Anderson | $33 → $32 | Maintains | In-Line | Get Alert |
05/17/2023 | Buy Now | 1.05% | Morgan Stanley | Ricky Goldwasser | $29 → $28 | Maintains | Underweight | Get Alert |
05/17/2023 | Buy Now | 62.4% | Needham | Scott Berg | → $45 | Reiterates | Buy → Buy | Get Alert |
05/01/2023 | Buy Now | 33.53% | Wells Fargo | Stan Berenshteyn | $39 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
02/17/2023 | Buy Now | 8.26% | JP Morgan | Anne Samuel | $60 → $30 | Maintains | Underweight | Get Alert |
The latest price target for Doximity (NYSE: DOCS) was reported by Needham on May 17, 2024. The analyst firm set a price target for $0.00 expecting DOCS to fall to within 12 months (a possible -100.00% downside). 23 analyst firms have reported ratings in the last year.
The latest analyst rating for Doximity (NYSE: DOCS) was provided by Needham, and Doximity reiterated their hold rating.
The last upgrade for Doximity Inc happened on April 25, 2024 when JP Morgan raised their price target to $25. JP Morgan previously had an underweight for Doximity Inc.
The last downgrade for Doximity Inc happened on August 9, 2023 when Guggenheim changed their price target from N/A to N/A for Doximity Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on May 17, 2024 so you should expect the next rating to be made available sometime around May 17, 2025.
While ratings are subjective and will change, the latest Doximity (DOCS) rating was a reiterated with a price target of $0.00 to $0.00. The current price Doximity (DOCS) is trading at is $27.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.